A Cancer-Pain Analgesia as Prolonging Strategy of Surviving Time after Failure of Adjuvant Chemotherapy in Patient with Progressive Bone-Metastatic Hepatocellular Carcinoma

A Cancer-Pain Analgesia as Prolonging Strategy of Surviving Time after Failure of Adjuvant Chemotherapy in Patient with Progressive Bone-Metastatic Hepatocellular Carcinoma

The hepatocellular carcinoma (HCC) with intrahepatic and bone metastasis shows poor survival of averagely 3 months. The bone metastasis and HCC itself might cause cancer-associated pain. An intrathecal (IT) analgesia might contribute to improve QOL and prolong surviving time (ST). A 71-year-old male...

Full description

Bibliographic Details
Main Authors: Yuji Inada, Seiji Hattori, Yasuhiko Fujita, Teruyoshi Amagai
Format: Article
Language:English
Published: Karger Publishers 2022-06-01
Series:Case Reports in Gastroenterology
Subjects:
hepatocellular carcinoma
bone metastasis
cancer-related pain
intrathecal analgesia
surviving time
Online Access:https://www.karger.com/Article/FullText/525118

Internet

https://www.karger.com/Article/FullText/525118

Similar Items